These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 29542413)

  • 21. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
    Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK
    Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical Discoveries on Multi-Target Approach to Manage Alzheimer's Disease.
    Batool A; Kamal MA; Rizvi SMD; Rashid S
    Curr Drug Metab; 2018; 19(8):704-713. PubMed ID: 29512457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening Methodologies.
    Nikolic K; Mavridis L; Djikic T; Vucicevic J; Agbaba D; Yelekci K; Mitchell JB
    Front Neurosci; 2016; 10():265. PubMed ID: 27375423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
    Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N
    Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MTDL design strategy in the context of Alzheimer's disease: from lipocrine to memoquin and beyond.
    Bolognesi ML; Rosini M; Andrisano V; Bartolini M; Minarini A; Tumiatti V; Melchiorre C
    Curr Pharm Des; 2009; 15(6):601-13. PubMed ID: 19199985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computational approach to suggest a new multi-target-directed ligand as a potential medication for Alzheimer's disease.
    Eslami M; Nezafat N; Negahdaripour M; Ghasemi Y
    J Biomol Struct Dyn; 2019 Nov; 37(18):4825-4839. PubMed ID: 30689517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-Target-Directed Ligands as an Effective Strategy for the Treatment of Alzheimer's Disease.
    Kumar B; Thakur A; Dwivedi AR; Kumar R; Kumar V
    Curr Med Chem; 2022; 29(10):1757-1803. PubMed ID: 33982650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In silico screening of glycogen synthase kinase-3β targeted ligands against acetylcholinesterase and its probable relevance to Alzheimer's disease.
    Jabir NR; Shakil S; Tabrez S; Khan MS; Rehman MT; Ahmed BA
    J Biomol Struct Dyn; 2021 Sep; 39(14):5083-5092. PubMed ID: 32588759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. De-novo Drug Design, Molecular Docking and In-Silico Molecular Prediction of AChEI Analogues through CADD Approaches as Anti-Alzheimer's Agents.
    Pandey S; Singh BK
    Curr Comput Aided Drug Des; 2020; 16(1):54-72. PubMed ID: 30827255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combining in vitro and in silico Approaches to Find New Candidate Drugs Targeting the Pathological Proteins Related to the Alzheimer's Disease.
    Li H; Wang X; Yu H; Zhu J; Jin H; Wang A; Yang Z
    Curr Neuropharmacol; 2018; 16(6):758-768. PubMed ID: 29086699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methodologies Related to Computational Models in View of Developing Anti-Alzheimer Drugs: An Overview.
    Baheti K; Kale M
    Curr Drug Discov Technol; 2019; 16(1):66-73. PubMed ID: 29663890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of ligand-based drug design methodologies toward the discovery of new anti- Alzheimer agents: futures perspectives in Fragment-Based Ligand Design.
    Speck-Planche A; Luan F; Cordeiro MN
    Curr Med Chem; 2012; 19(11):1635-45. PubMed ID: 22376033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR).
    Ferreira JPS; Albuquerque HMT; Cardoso SM; Silva AMS; Silva VLM
    Eur J Med Chem; 2021 Oct; 221():113492. PubMed ID: 33984802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer's Disease, the "One-Molecule, One-Target" Paradigm, and the Multitarget Directed Ligand Approach.
    Oset-Gasque MJ; Marco-Contelles J
    ACS Chem Neurosci; 2018 Mar; 9(3):401-403. PubMed ID: 29465220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018).
    Mishra P; Kumar A; Panda G
    Bioorg Med Chem; 2019 Mar; 27(6):895-930. PubMed ID: 30744931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystamine-tacrine dimer: a new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment.
    Minarini A; Milelli A; Tumiatti V; Rosini M; Simoni E; Bolognesi ML; Andrisano V; Bartolini M; Motori E; Angeloni C; Hrelia S
    Neuropharmacology; 2012 Feb; 62(2):997-1003. PubMed ID: 22032870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Linkers and Substitutions on Multitarget Directed Ligands for Alzheimer's Diseases: Emerging Paradigms and Strategies.
    Pravin N; Jozwiak K
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential Therapeutic Approaches to Alzheimer's Disease By Bioinformatics, Cheminformatics And Predicted Adme-Tox Tools.
    Avram S; Mernea M; Limban C; Borcan F; Chifiriuc C
    Curr Neuropharmacol; 2020; 18(8):696-719. PubMed ID: 31885353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sarsasapogenin: A steroidal saponin from Asparagus racemosus as multi target directed ligand in Alzheimer's disease.
    Kashyap P; Muthusamy K; Niranjan M; Trikha S; Kumar S
    Steroids; 2020 Jan; 153():108529. PubMed ID: 31672628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protocol for fast screening of multi-target drug candidates: Application to Alzheimer's disease.
    Thai NQ; Nguyen HL; Linh HQ; Li MS
    J Mol Graph Model; 2017 Oct; 77():121-129. PubMed ID: 28850894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.